Audience

GLP-1 Considerers panel (US)

GLP-1 Considerers (US): a public Ask Brox audience of Brox clones, each built from a long-form interview with a real person. Every insight fielded on this panel, newest first.

2 insights·0 studies

What did the GLP-1 Considerers panel say?

  1. #

    65.5%

    65.5% of GLP-1 considerers would turn to diet, exercise or a program (34.5%) or put treatment off (30.9%) if their plan dropped weight-loss coverage; 11.5% would pay a drug maker's cash price. — When a plan drops GLP-1 weight-loss coverage, 65.5% of considerers turn away from medicine, not to cash, yet 80.6% would switch plans to keep it

    base 139

  2. #

    70.8%

    70.8% of never-users considering a GLP-1 say the monthly cost is the one concern that most holds them back, far ahead of not being sure it is medically right (13.9%) and side effects (11.7%). — GLP-1 considerers: cost holds back 70.8%, and starting only becomes likely near $49 a month

    base 137

What has Brox published on glp-1 considerers panel (us)?Newest first

What do people ask about glp-1 considerers panel (us)?

When a health plan drops GLP-1 weight-loss coverage, what do people considering the drug do instead?
When a health plan drops GLP-1 weight-loss coverage, 65.5% of US GLP-1 considerers would turn to diet and exercise or put treatment off rather than take any medicine, and only 11.5% would pay a drug maker's $350 to $500 cash price (n=139, October 2026).Read the insight
What would make someone considering a GLP-1 weight-loss medication actually start?
The monthly cost is the main thing holding back 70.8% of US adults considering a GLP-1 weight-loss medication who have never taken one (n=137, September 2026), and without insurance only 2.2% would be likely to start at $499 a month against 53.3% at $49.Read the insight

Other audiences

How should you read these findings?

Where the numbers come from. Every figure on this site is a predicted response from Brox clones: behavioural replicas of real people, each built from a long-form interview with that person. The base under each figure is the number of clones behind it.

Where the real data comes from. The long-form video interviews with the real people the clones are built from. A quote is always shown with the interview line it was predicted from.

What you can take away. Insights publish their tabulation as CSV and JSON: question, option, count, percentage and base. Never per-person rows.

Ask this of your own customers: humans@brox.ai